IL37 and cirrhosis of liver: To assess the influence of IL-37 polymorphism on the risk of HBV-mediated liver disease progression to end-stage liver diseases (liver cirrhosis and/or HCC), the genotype and allelic distributions were analyzed between patients actively infected with HBV and the patients diagnosed with liver cirrhosis with and without HCC.